Edesa Biotech, Inc.
EDSA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001540159
No open-market purchases or sales by Edesa Biotech, Inc. insiders were filed in the last 90 days; 33 institutions reported holding it in 13F filings for Q2 2026, worth $30.0M in total; no superinvestor holds it.
Q4 2021 vs. Q3 2021
How the institutions holding Edesa Biotech, Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Q4 2021 | Change |
|---|---|---|---|
| Holders | 23 | 26 | +3 |
| Shares | 385.6K | 361.5K | −24.0K (−6.2%) |
| Value | $2.85M | $2.03M | −$818.5K (−28.7%) |
New holders (9)
Institutions that held Edesa Biotech, Inc. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Renaissance Technologies LLC | 33,100 | $186.0K | 0.00% |
| Citadel Advisors LLC | 15,082 | $85.0K | 0.00% |
| Two Sigma Investments, LP | 12,617 | $71.0K | 0.00% |
| TD Waterhouse Canada Inc. | 1,000 | $5.73K | 0.00% |
| National Bank of Canada | 618 | $3.00K | 0.00% |
| BlackRock Inc. | 518 | $3.00K | 0.00% |
| Bank of America Corp | 16 | $0 | 0.00% |
| Aquire Wealth Advisors, LLC | 43 | $0 | 0.00% |
| Fortitude Advisory Group L.L.C. | 2 | $0 | 0.00% |
Sold out (6)
Institutions that held Edesa Biotech, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| 180 Wealth Advisors, LLC | 20,000 | $156.0K |
| Verition Fund Management LLC | 13,502 | $100.0K |
| FNY Investment Advisers, LLC | 1,640 | $12.0K |
| Barclays PLC | 300 | $2.00K |
| American Portfolios Advisors | 2 | $15 |
| Harbour Investments, Inc. | 28 | $0 |